UK becomes first country to license 3 parent babies

Published On 2016-12-16 03:57 GMT   |   Update On 2016-12-16 03:57 GMT

London: Britain became the first country to formally licence an in-vitro fertilisation (IVF) treatment designed to create babies from three people. UK's Human Fertilisation and Embryology Authority (HFEA) gave the final go-ahead for the treatment known as mitochondrial replacement therapy (MRT), which doctors say can help prevent incurable inherited diseases. The treatment is informally...

Login or Register to read the full article
London: Britain became the first country to formally licence an in-vitro fertilisation (IVF) treatment designed to create babies from three people. UK's Human Fertilisation and Embryology Authority (HFEA) gave the final go-ahead for the treatment known as mitochondrial replacement therapy (MRT), which doctors say can help prevent incurable inherited diseases. The treatment is informally called "three-parent" IVF because the babies, born from genetically modified embryos, would have DNA from a mother, a father and from a female donor.

MRT is designed to prevent mitochondrial diseases from being passed on by replacing the mother's defective mitochondria with those from a healthy donor. The resulting baby would have the usual 23 pairs of chromosomes from both parents, but with mitochondria from the healthy donor. The procedure also raises ethical concerns. Because the genetic manipulation affects all of the cells in the embryo, any glitches the procedure might introduce could potentially be passed down to future generations.

The decision means the first babies created by the technique in the UK could be born as early as 2017. The government's chief scientific adviser, Mark Walport, praised the decision as a "careful and considered" assessment.

The world's first "three-parent" baby was born in September this year in Mexico. agencies
Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News